Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: heartburn US FDA label
- sodium alginate no separate page
Use: to raise plasma pH in adult and pediatric patients with clinically significant metabolic acidosis. US FDA label
Kidney dosing: Sodium bicarbonate (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- IV for metabolic acidosis (adults and children 2 years and older): 2 to 5 mEq/kg over 4 to 8 hours, by bicarbonate, total CO2, pH and clinical state (label). Treat the cause.
- CrCl 30–59 mL/min
- No kidney dose change in the label. Kidney disease and anuria increase sensitivity to the sodium load: watch for fluid overload, edema and blood pressure, and adjust other sodium sources (label 5.1). Monitor bicarbonate, sodium and potassium; avoid overshoot alkalosis. Oral tablets for CKD metabolic acidosis: consider treatment to keep serum bicarbonate from falling below 18 mmol/L, and do not overshoot the upper limit of normal; watch blood pressure, potassium and fluid status (KDIGO 2024 PP 3.10.1, 3.10.2). Each 650 mg tablet supplies about 7.7 mEq of sodium and bicarbonate (325 mg about 3.9 mEq); 8.4% solution is 1 mEq/mL (84 mg per mEq; label 3: 12.6 mg/mL = 0.150 mEq/mL). Oral doses are not in the label.
- CrCl 15–29 mL/min
- No kidney dose change in the label. Kidney disease and anuria increase sensitivity to the sodium load: watch for fluid overload, edema and blood pressure, and adjust other sodium sources (label 5.1). Monitor bicarbonate, sodium and potassium; avoid overshoot alkalosis. Oral tablets for CKD metabolic acidosis: consider treatment to keep serum bicarbonate from falling below 18 mmol/L, and do not overshoot the upper limit of normal; watch blood pressure, potassium and fluid status (KDIGO 2024 PP 3.10.1, 3.10.2). Each 650 mg tablet supplies about 7.7 mEq of sodium and bicarbonate (325 mg about 3.9 mEq); 8.4% solution is 1 mEq/mL (84 mg per mEq; label 3: 12.6 mg/mL = 0.150 mEq/mL). Oral doses are not in the label.
- CrCl <15 mL/min (not on dialysis)
- No kidney dose change in the label. Kidney disease and anuria increase sensitivity to the sodium load: watch for fluid overload, edema and blood pressure, and adjust other sodium sources (label 5.1). Monitor bicarbonate, sodium and potassium; avoid overshoot alkalosis. Oral tablets for CKD metabolic acidosis: consider treatment to keep serum bicarbonate from falling below 18 mmol/L, and do not overshoot the upper limit of normal; watch blood pressure, potassium and fluid status (KDIGO 2024 PP 3.10.1, 3.10.2). Each 650 mg tablet supplies about 7.7 mEq of sodium and bicarbonate (325 mg about 3.9 mEq); 8.4% solution is 1 mEq/mL (84 mg per mEq; label 3: 12.6 mg/mL = 0.150 mEq/mL). Oral doses are not in the label.
- Hemodialysis (intermittent)
- No dose change; anuria raises the risk of fluid overload from the sodium load (label 5.1). Dialysate bicarbonate also corrects acidosis; coordinate with the dialysis prescription (clinical judgment).
- Peritoneal dialysis
- No dose change; watch sodium load and fluid status (label 5.1).
- CRRT
- No data in label. CRRT fluids are usually bicarbonate-buffered; added IV bicarbonate is a specialist decision guided by blood gases.
- Dialyzable? Bicarbonate crosses dialysis membranes in both directions according to the dialysate bicarbonate concentration (physiology; not stated in label).
- Monitoring Blood gases or serum bicarbonate, sodium, potassium (hypokalemia as acidosis corrects), fluid status, blood pressure, edema. Extravasation site (hypertonic solutions).
From the Sodium bicarbonate monograph (renalcarematters.com, reviewed).
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Oral suspension: 500 mg +213 mg + 325 mg, 500 mg/213 mg/325 mg per 10 mL, 500 mg/267 mg/160 mg per 10 mL
- Chewable tablet: 250 mg/106.5 mg/187.5 mg, 250 mg/133.5 mg/80 mg
- Suspension: 50 mg/26.7 mg/16 mg per mL, 500 mg/213 mg/325 mg per 10 mL
Registered products in the Philippines
20 products registered with the Food and Drug Administration (FDA) Philippines list Calcium carbonate + Sodium alginate + Sodium bicarbonate as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products20
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AlgicoreSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 500 mg/213 mg/325 mg per 10 mL Oral SuspensionAluminum Foil Sachet x 10 mL (Box of 12's and 24's) | OTC | Enicar Pharmaceuticals Pvt. Ltd.India | Altomed Pharmaceuticals, Inc.Importer: Ollen Pharma Trading, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-12184-03 | Jun 27, 2027 | |
AlginaSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 500 mg / 213 mg / 325 mg per 10 mL Oral SuspensionPET/PE/Alu/PE/EAA Stick Sachet x 10 mL (Box of 100's) | OTC | Genuone Sciences Inc.Republic of Korea | UNILAB, Inc. | DRP-7065 | Feb 23, 2032 | |
AvisaphSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 500 mg/ 213 mg/ 325 mg per 10 mL Oral SuspensionAluminum Foil Sachet x 10 mL (Box of 12's and 24's) | OTC | Enicar Pharmaceuticals Pvt. Ltd.India | Ollen Pharma Trading Inc. | DRP-12184 | Jun 21, 2027 | |
AzacidSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 500mg/213mg/325mg per 10 mL Oral SuspensionAluminum Foil Sachet Pack x 10 mL (Box of 10's, 30's and 50's) | OTC | Azarias Pharmaceutical Laboratories Inc.,Philippines | — | DRP-18458 | Jul 17, 2031 | |
AzconSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 500 mg/213 mg/325 mg per 10 mL Oral SuspensionAluminum Foil Sachet x 10 mL (Box of 12's and 24's) | OTC | Enicar Pharmaceuticals Pvt. Ltd.India | A-Z Market Enterprise Developers Inc.Importer: Ollen Pharma Trading Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-12184-02 | Jun 27, 2027 | |
GascovidSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 50mg/26.7mg/16mg per mL Suspension (Peppermint Flavor)Amber PET Bottle x 150 mL (Box of 1's) | OTC | Hovid BerhadMalaysia | Hovid Inc. | DRP-12566 | Sep 2, 2027 | |
Gascovid Double ActionSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 250mg/106.5mg/187.5 mg Chewable TabletAlu/PVC Blister Pack x 6's (Box of 6's); Alu/PVC Blister Pack x 6's (Box of 12's); Alu/PVC Blister Pack x 6's (Box of 60's) | OTC | Hovid BerhadMalaysia | Hovid Inc | DRP-10563 | Oct 15, 2031 | |
GaslifeSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 500 mg / 267 mg / 160 mg per 10 mL Oral SuspensionAluminum Foil Sachet x 10 mL (Box of 12's); Aluminum Foil Sachet x 10 mL (Box of 24's) | OTC | Nucare Labs LLPIndia | Biophil Medical Equipment And Supplies Trading | DRP-17818 | Mar 16, 2031 | |
Gastrovia Duo ReliefSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 500 mg +213 mg + 325 mg Oral SuspensionAlu-Alu Film Sachet X 10 mL (Box of 25's) | OTC | Ciron Drugs & Pharmaceuticals Pvt. Ltd. | Despina Pharma Inc. | DRP-18461 | Jul 22, 2031 | |
Gavisaph-DASodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 250 mg/ 106.5 mg/ 187.5 mg Chewable TabletAlu/PVC Blister Pack x 10’s x 10 Strip (Box of 100’s) | OTC | Genom Biotech Pvt. Ltd.India | Nelpa Lifesciences, Inc. | DRP-16381 | Oct 19, 2031 | |
GavisconSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 250 mg/ 133.5 mg/ 80 mg Chewable TabletPVC Blister Pack x 8's (Box of 96's) | OTC | Reckitt Benckiser Healthcare (UK) LimitedUnited Kingdom | Importer: Reckitt Benckiser Healthcare (Philippines), Inc. | DR-XY35582 | Mar 11, 2029 | |
GavisconSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 500 mg/ 267 mg/ 160 mg per 10 mL Oral Suspension150 mL Amber Glass Bottle | OTC | Reckitt Benckiser Healthcare (UK) LimitedUnited Kingdom | Reckitt Benckiser Healthcare (Philippines), Inc. | DR-XY34746 | Jul 25, 2028 | |
GavisconSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 500 mg/ 267 mg/ 160 mg per 10 mL Oral suspensionAluminum Foil Sachet x 10 mL (Box of 5's); Aluminum Foil Sachet x 10 mL (Box of 12's); Aluminum Foil Sachet x 10 mL (Box of 24's) | OTC | Reckitt Benckiser Healthcare (UK) LtdEngland | Reckitt Benckiser Healthcare (Philippines), Inc. | DR-XY34907 | Sep 9, 2028 | |
Gaviscon Double ActionSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 250 mg/106.5 mg/187.5 mg Chewable TabletAlu/PVC/PE/PVDC (Triplex) blister pack x 8's (Box of 8's and 96's) | OTC | RECKITT BENCKISER HEALTHCARE (UK) LIMITEDUnited Kingdom | RECKITT BENCKISER HEALTHCARE (PHILIPPINES), INC. | DR-XY43658 | Aug 22, 2029 | |
Gaviscon Double ActionSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 250 mg/106.5 mg/187.5 mg Chewable Tablet (Mixed Berries Flavor)PVC/PVdC Blister x 8's (Box of 8's) | OTC | Reckitt Benckiser Healthcare (UK) LimitedUnited Kingdom | Importer: Reckitt Benckiser Heathcare (Philippines) Inc. | DR-XY46902 | Jun 1, 2037 | |
Gaviscon Double ActionSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 500 mg/213 mg/325 mg per 10 mL Suspension10 mL Aluminum Foil Sachet (Box of 5's); 10 mL Aluminum Foil Sachet (Box of 12's); 10 mL Aluminum Foil Sachet (Box of 24's) | OTC | RECKITT BENCKISER HEALTHCARE (UK) LIMITEDUnited Kingdom | Importer: RECKITT BENCKISER HEALTHCARE (PHILIPPINES), INC. | DR-XY43337 | Apr 3, 2029 | |
Kremil-S Cool ReliefSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 500 mg / 213 mg / 325 mg per 10 mL Oral SuspensionPET/PE/Alu/PE/EAA Stick Sachet x 10 mL (Box of 100's) | OTC | Genuone Sciences Inc.Republic of Korea | UH Pharma Inc.Importer: UNILAB, Inc. | DRP-7065-01 | Feb 23, 2037 | |
Saphagel-PlusSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 500 mg/213mg/ 325mg per 10mL Oral Suspension | OTC | Sai Parenterals Ltd.India | Nelpa Lifesciences, Inc. | DRP-17647 | Feb 11, 2031 | |
SaphalgenSodium Alginate + Sodium Bicarbonate + Calcium Carbonate | 500 mg/ 267 mg/ 160 mg per 10mL Oral Suspension | OTC | Sai Parenterals Ltd.India | Nelpa Lifesciences, Inc. | DRP-17646 | Feb 11, 2031 | |
TumiwelSodium Alginate Sodium Bicarbonate + Calcium Carbonate | 500mg/213mg/ 325mg per 10 mL Oral SuspensionHDPE Bottle x 60mL (Box of 1's) | OTC | LifeSquare Laboratories Inc.Philippines | — | DRP-15021 | Mar 13, 2029 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .